Literature DB >> 8486785

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

H Itoh1, M Mukoyama, R E Pratt, G H Gibbons, V J Dzau.   

Abstract

Angiotensin (Ang) II stimulates hypertrophic growth of vascular smooth muscle cells (VSMC). Accompanying this growth is the induction of the expression of growth-related protooncogenes (c-fos, c-jun, and c-myc), as well as the synthesis of the autocrine growth factors, such as PDGF-A and TGF-beta 1. In this study, we demonstrate further that Ang II also induces the synthesis of basic fibroblast growth factor (bFGF), a potent mitogen for VSMC. To examine how these factors interact to modulate the growth response of VSMC to Ang II, we used antisense oligomers to determine the relative contribution of these three factors. Treatment of confluent, quiescent smooth muscle cells with specific antisense oligomers complementary to bFGF, PDGF-A, and TGF-beta 1 efficiently inhibited the syntheses of these factors. Our results demonstrate that in these VSMC, TGF-beta 1 affects a key antiproliferative action, modulating the mitogenic properties of bFGF. Autocrine PDGF exerts only a minimal effect on DNA synthesis. An imbalance in these signals activated by Ang II may result in abnormal VSMC growth leading to the development of vascular disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486785      PMCID: PMC288230          DOI: 10.1172/JCI116454

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

Review 1.  Significance of the vascular renin-angiotensin pathway.

Authors:  V J Dzau
Journal:  Hypertension       Date:  1986-07       Impact factor: 10.190

2.  Transforming growth factor-beta inhibits endothelial cell proliferation.

Authors:  M Fràter-Schröder; G Müller; W Birchmeier; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

Review 3.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

4.  Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted.

Authors:  I Vlodavsky; R Fridman; R Sullivan; J Sasse; M Klagsbrun
Journal:  J Cell Physiol       Date:  1987-06       Impact factor: 6.384

5.  Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.

Authors:  M Campbell-Boswell; A L Robertson
Journal:  Exp Mol Pathol       Date:  1981-10       Impact factor: 3.362

6.  Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide.

Authors:  H Itoh; M Mukoyama; R E Pratt; V J Dzau
Journal:  Biochem Biophys Res Commun       Date:  1992-11-16       Impact factor: 3.575

7.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark; P Lind; M S Urdea; R Eddy; T B Shows; K Philpott; A L Mellor
Journal:  Nature       Date:  1986 Apr 24-30       Impact factor: 49.962

8.  Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth.

Authors:  L Schweigerer; G Neufeld; J Friedman; J A Abraham; J C Fiddes; D Gospodarowicz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

9.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.

Authors:  O Saksela; D Moscatelli; D B Rifkin
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor.

Authors:  M Klagsbrun; J Sasse; R Sullivan; J A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more
  66 in total

1.  Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system.

Authors:  Y Asada; T Yamazawa; K Hirose; T Takasaka; M Iino
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.

Authors:  M J Mann; R Morishita; G H Gibbons; H E von der Leyen; V J Dzau
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 4.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

5.  The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.

Authors:  V I Skvortsova; I A Platonova; T V Tvorogova; O V Volkovenko; L I Demidova; I V Ostrovtsev
Journal:  Neurosci Behav Physiol       Date:  2004-11

Review 6.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

7.  Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.

Authors:  D S Taylor; X Cheng; J E Pawlowski; A R Wallace; P Ferrer; C J Molloy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

Review 9.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

10.  Renin-angiotensin system polymorphisms and renal scarring.

Authors:  Rafael Pardo; Serafín Málaga; Eliecer Coto; Mercedes Navarro; Victoria Alvarez; Laura Espinosa; Ruth Alvarez; Alfredo Vallo; Cesar Loris; Socorro Braga
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.